Sichuan Kelun Pharmaceutical (002422.SZ) subsidiary presented multiple innovative drug research results at the 2026 European Society for Medical Oncology Congress

11:46 26/10/2026

Sichuan Kelun Pharmaceutical (002422.SZ) announced that the company recently learned that its controlled subsidiary Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech") presented multiple clinical research results at the 2026 European Society for Medical Oncology (ESMO) Congress held in Madrid, Spain, from October 23 to 27, covering relevant data on the TROP2-targeting antibody-drug conjugate (ADC) sac-TMT (Jia Tailai) and the B7-H3-targeting ADC SKB500.

Sichuan Kelun Pharmaceutical (002422.SZ) announced that the company recently learned that its controlled subsidiary Sichuan SKB BIO Pharmaceutical Co., Ltd. (referred to as "Kelun-Biotech") presented multiple clinical research results at the 2026 European Society for Medical Oncology (ESMO) Congress held in Madrid, Spain, from October 23 to 27, covering relevant data on the TROP2-targeting antibody-drug conjugate (ADC) sac-TMT (Jia Tailai) and the B7-H3-targeting ADC SKB500.

RMB13.29 million! YIDU TECH (02158) wins bid for the First Affiliated Hospital of Chongqing Medical University's next-generation big data platform project, continuing to expand its medical data foundation layout in Grade 3A hospitals.

POLYFAIR HLDGS (08532) suspended trading from the morning of October 26.

MAGNUSCONCORDIA (01172) subsidiary and Sichuan Juxinghua Trading separately entered into sale and purchase agreements for the purchase and sale of properties

POLYFAIR HLDGS (08532) suspended trading from the morning of October 26.

MAGNUSCONCORDIA (01172) subsidiary and Sichuan Juxinghua Trading separately entered into sale and purchase agreements for the purchase and sale of properties